Short Interest in PureTech Health plc Declines 15.7%

The biopharmaceutical company's stock saw a drop in short positions last month.

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

PureTech Health plc (OTCMKTS:PTCHF), a clinical-stage biopharmaceutical company focused on developing innovative medicines, saw a significant 15.7% decline in short interest in its stock during February. As of February 13th, there were 47,681 shares shorted, down from 56,594 shares at the end of January.

Why it matters

Fluctuations in short interest can provide insights into investor sentiment and market expectations around a company's stock. The decrease in short positions for PureTech Health may signal growing optimism among some investors about the company's prospects.

The details

PureTech Health's stock opened at $1.70 per share on Wednesday. The company's shares have traded in a 52-week range between $1.27 and $1.90, with a current average daily trading volume of 120 shares. Based on this volume, the short-interest ratio is currently 397.3 days, meaning it would take nearly 400 days to cover all the outstanding short positions.

  • As of February 13th, 2026, there were 47,681 shares of PureTech Health stock shorted.
  • On January 29th, 2026, the short interest in PureTech Health was 56,594 shares.

The players

PureTech Health plc

A clinical-stage biopharmaceutical company focused on developing innovative medicines to address serious diseases with high unmet medical need.

Got photos? Submit your photos here. ›

The takeaway

The decline in short interest for PureTech Health's stock may signal growing optimism among some investors about the company's future prospects, though the stock's trading volume remains relatively low.